Hiroshi Kawano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hiroshi Kawano has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Yasuhiko Nishioka
Department of Respiratory Medicine and Rheumatology Graduate School of Biomedical Sciences, Tokushima University Tokushima Japan
2 shared publications - Yuko Toyoda
Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan
2 shared publications - Atsuro Saijo
Department of Respiratory Medicine, Shikoku Central Hospital of the Mutual Aid Association of Public School teachers, 2233 Kawanoe-cho, Shikoku-Chuo, 799-0193, Japan
1 shared publication - Fumitaka Ogushi
Division of Pulmonary Medicine, National Hospital Organization National Kochi Hospital, 1-2-25 Asakuranishimachi, Kochi 780-8077, Japan
1 shared publication - Haruka Nishimura
Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan
1 shared publication - Hisatsugu Goto
Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan
1 shared publication
Latest Publications
- 1 September 2019
- Published by Elsevier in Respiratory Investigation
- Vol. 57 (5) , 435-443
Clinical features of interstitial pneumonia associated with systemic lupus erythematosus
- 1 September 2019
- Published by Elsevier in Respiratory Investigation
- Vol. 57 (5) , 435-443
Clinical features of interstitial pneumonia associated with systemic lupus erythematosus
- 1 March 2017
- Published by Elsevier in Respiratory Investigation
- Vol. 55 (2) , 145-152
Analysis of acute exacerbation of interstitial lung disease associated with chemotherapy in patients with lung cancer: A feasibility of S-1
- 1 March 2017
- Published by Elsevier in Respiratory Investigation
- Vol. 55 (2) , 145-152
Analysis of acute exacerbation of interstitial lung disease associated with chemotherapy in patients with lung cancer: A feasibility of S-1